Cargando…

Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150076/
_version_ 1782144568774361088
collection PubMed
description
format Text
id pubmed-2150076
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-21500762009-09-10 Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours Br J Cancer Correction Nature Publishing Group 1998-05 /pmc/articles/PMC2150076/ Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
title Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
title_full Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
title_fullStr Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
title_full_unstemmed Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
title_short Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
title_sort phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150076/